医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
27期
635-636
,共2页
溃疡性结肠炎%美沙拉嗪%双歧三联活菌%疗效
潰瘍性結腸炎%美沙拉嗪%雙歧三聯活菌%療效
궤양성결장염%미사랍진%쌍기삼련활균%료효
Ulcerative colitis%Salad oxazine%Colon sanlian living bacterium
目的观察美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎的疗效。方法将86例溃疡性结肠炎患者分为两组，实验组行美沙拉嗪联合双歧三联活菌治疗，对照组行单纯美沙拉嗪治疗。结果实验组总有效率为97.73%，对照组总有效率为73.81%，两组对比差异性显著，有统计学意义(<0.05)。不良反应发生率实验组为9.09%，对照组为7.14%，差异无统计学意义(跃0.05)。结论美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎，总有效率高，不良反应少。
目的觀察美沙拉嗪聯閤雙歧三聯活菌治療潰瘍性結腸炎的療效。方法將86例潰瘍性結腸炎患者分為兩組，實驗組行美沙拉嗪聯閤雙歧三聯活菌治療，對照組行單純美沙拉嗪治療。結果實驗組總有效率為97.73%，對照組總有效率為73.81%，兩組對比差異性顯著，有統計學意義(<0.05)。不良反應髮生率實驗組為9.09%，對照組為7.14%，差異無統計學意義(躍0.05)。結論美沙拉嗪聯閤雙歧三聯活菌治療潰瘍性結腸炎，總有效率高，不良反應少。
목적관찰미사랍진연합쌍기삼련활균치료궤양성결장염적료효。방법장86례궤양성결장염환자분위량조，실험조행미사랍진연합쌍기삼련활균치료，대조조행단순미사랍진치료。결과실험조총유효솔위97.73%，대조조총유효솔위73.81%，량조대비차이성현저，유통계학의의(<0.05)。불량반응발생솔실험조위9.09%，대조조위7.14%，차이무통계학의의(약0.05)。결론미사랍진연합쌍기삼련활균치료궤양성결장염，총유효솔고，불량반응소。
Objective To observe the salad oxazine combined dichotomous sanlian living bacterium curative ef ect for the treatment of ulcerative colitis. Methods 86 patients with ulcerative colitis were divided into 2 groups, experimental group line beauty salad oxazine combined therapy with the colon sanlian living bacterium, the control group treated pure beauty salad lamictal. Results The total effective rate was 97.73%, control group total ef ective rate was 73.81%, the boundary of comparing the two groups have statistical significance ( < 0.05). Incidence of adverse reactions to the experimental group was 9.09%, the control group was 7.14%, there was no statistically significant dif erence ( >0.05). Conclusion The salad oxazine combined dichotomous sanlian live bacteria in the treatment of ulcerative colitis, total ef ective rate is high, less adverse reaction.
